This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Aug 25;23(17):9617.

doi: 10.3390/ijms23179617.

Molecular Research and Treatment of Breast Cancer

Affiliations

PMID: 36077013
PMCID: PMC9455640
DOI: 10.3390/ijms23179617

Editorial

Molecular Research and Treatment of Breast Cancer

Anna Kawiak. Int J Mol Sci. 2022.

. 2022 Aug 25;23(17):9617.

doi: 10.3390/ijms23179617.

Author

Affiliation

¹ Intercollegiate Faculty of Biotechnology, University of Gdansk, Abrahama 58, 80-307 Gdansk, Poland.

PMID: 36077013
PMCID: PMC9455640
DOI: 10.3390/ijms23179617

Abstract

Breast cancer is the leading cause of cancer-related deaths in the female population [...].

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants.
Lukong KE, Ogunbolude Y, Kamdem JP. Lukong KE, et al. Breast Cancer Res Treat. 2017 Nov;166(2):351-365. doi: 10.1007/s10549-017-4408-0. Epub 2017 Aug 4. Breast Cancer Res Treat. 2017. PMID: 28776284 Review.
Breast cancer in Russia.
Garin AM. Garin AM. Breast Cancer. 2004;11(1):7-9. doi: 10.1007/BF02967993. Breast Cancer. 2004. PMID: 14718784 No abstract available.
[Breast cancer].
Bol P. Bol P. Ned Tijdschr Tandheelkd. 1998 Sep;105(9):330-1. Ned Tijdschr Tandheelkd. 1998. PMID: 11928444 Review. Dutch. No abstract available.
[Third revision of the National Consensus on Diagnosis and Treatment of Breast Cancer (third of three parts)].
[No authors listed] [No authors listed] Ginecol Obstet Mex. 2010 Mar;78(3):199-212. Ginecol Obstet Mex. 2010. PMID: 20939226 Spanish.
Breast cancer: presentation, investigation and management.
Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Katsura C, et al. Br J Hosp Med (Lond). 2022 Feb 2;83(2):1-7. doi: 10.12968/hmed.2021.0459. Epub 2022 Feb 7. Br J Hosp Med (Lond). 2022. PMID: 35243878 Review.

See all similar articles

Cited by

Research progress of cancer cell membrane coated nanoparticles for the diagnosis and therapy of breast cancer.
Zhou Z, Zhang S, Xue N. Zhou Z, et al. Front Oncol. 2023 Sep 14;13:1270407. doi: 10.3389/fonc.2023.1270407. eCollection 2023. Front Oncol. 2023. PMID: 37781205 Free PMC article. Review.
From Microbial Homeostasis to Systemic Pathogenesis: A Narrative Review on Gut Flora's Role in Neuropsychiatric, Metabolic, and Cancer Disorders.
Yan X, Shi L, Zhu X, Zhao Y, Luo J, Li Q, Xu Z, Zhao J. Yan X, et al. J Inflamm Res. 2025 Jul 5;18:8851-8873. doi: 10.2147/JIR.S531671. eCollection 2025. J Inflamm Res. 2025. PMID: 40635765 Free PMC article. Review.
Development and Validation of a Nomogram for Predicting Survival Based on Ferritin and Transferrin Ratio in Breast Cancer Patients.
Huang S, Lai H, Pan X, Lin Q, Qin Y, Liu F, Fang M, Huang W, Wei C. Huang S, et al. Cancer Control. 2024 Jan-Dec;31:10732748241261553. doi: 10.1177/10732748241261553. Cancer Control. 2024. PMID: 38850515 Free PMC article.
Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer.
Ji Y, Li R, Tang G, Xiao Y, Ye R, Shi J, Geng C, Ran R, Zhu C, Wang W, Chen C, Yang Q. Ji Y, et al. Cell Mol Life Sci. 2025 Jul 14;82(1):275. doi: 10.1007/s00018-025-05788-5. Cell Mol Life Sci. 2025. PMID: 40658144 Free PMC article.
Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition.
Feng H, He L, Umar T, Wang X, Li W, Zhang B, Zhu X, Deng G, Qiu C. Feng H, et al. Curr Issues Mol Biol. 2025 May 29;47(6):403. doi: 10.3390/cimb47060403. Curr Issues Mol Biol. 2025. PMID: 40699802 Free PMC article.

See all "Cited by" articles

References

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
1. Lüönd F., Tiede S., Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br. J. Cancer. 2021;125:164–175. - PMC - PubMed
1. Vallon-Christersson J., Häkkinen J., Hegardt C., Saal L.H., Larsson C., Ehinger A., Lindman H., Olofsson H., Sjöblom T., Wärnberg F., et al. Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series. Sci. Rep. 2019;9:12184. doi: 10.1038/s41598-019-48570-x. - DOI - PMC - PubMed
1. Belluti S., Rigillo G., Imbriano C. Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates. Cells. 2020;9:760. doi: 10.3390/cells9030760. - DOI - PMC - PubMed
1. Ogura T., Azuma K., Sato J., Kinowaki K., Takayama K.-I., Takeiwa T., Kawabata H., Inoue S. OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH. Int. J. Mol. Sci. 2021;22:11505. doi: 10.3390/ijms222111505. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information